ACT Stock Overview
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
AlzChem Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €46.80 |
| 52 Week High | €46.90 |
| 52 Week Low | €17.70 |
| Beta | 1.1 |
| 1 Month Change | 40.12% |
| 3 Month Change | 88.71% |
| 1 Year Change | 141.24% |
| 3 Year Change | 82.10% |
| 5 Year Change | 112.73% |
| Change since IPO | 74.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACT | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 5.4% | -1.4% | -2.0% |
| 1Y | 141.2% | -1.2% | -0.3% |
Return vs Industry: ACT exceeded the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: ACT exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| ACT volatility | |
|---|---|
| ACT Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ACT's share price has been volatile over the past 3 months.
Volatility Over Time: ACT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1908 | 1,607 | Andreas Niedermaier | www.alzchem.com |
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.
AlzChem Group AG Fundamentals Summary
| ACT fundamental statistics | |
|---|---|
| Market cap | €474.22m |
| Earnings (TTM) | €34.62m |
| Revenue (TTM) | €545.79m |
13.7x
P/E Ratio0.9x
P/S RatioIs ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACT income statement (TTM) | |
|---|---|
| Revenue | €545.79m |
| Cost of Revenue | €241.72m |
| Gross Profit | €304.07m |
| Other Expenses | €269.45m |
| Earnings | €34.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | 3.40 |
| Gross Margin | 55.71% |
| Net Profit Margin | 6.34% |
| Debt/Equity Ratio | 35.2% |
How did ACT perform over the long term?
See historical performance and comparisonDividends
2.6%
Current Dividend Yield35%
Payout RatioDoes ACT pay a reliable dividends?
See ACT dividend history and benchmarks| AlzChem Group dividend dates | |
|---|---|
| Ex Dividend Date | May 08 2024 |
| Dividend Pay Date | May 10 2024 |
| Days until Ex dividend | 15 days |
| Days until Dividend pay date | 17 days |
Does ACT pay a reliable dividends?
See ACT dividend history and benchmarks